- Previous Close
187.71 - Open
189.01 - Bid 172.00 x 900
- Ask 195.23 x 800
- Day's Range
186.52 - 196.55 - 52 Week Range
123.00 - 257.40 - Volume
651,554 - Avg. Volume
654,517 - Market Cap (intraday)
5.762B - Beta (5Y Monthly) 1.31
- PE Ratio (TTM)
920.14 - EPS (TTM)
0.21 - Earnings Date Nov 5, 2024 - Nov 11, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
222.31
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
www.inspiresleep.comRecent News: INSP
View MorePerformance Overview: INSP
Trailing total returns as of 8/9/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INSP
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INSP
View MoreValuation Measures
Market Cap
5.76B
Enterprise Value
5.35B
Trailing P/E
920.14
Forward P/E
250.00
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.09
Price/Book (mrq)
9.03
Enterprise Value/Revenue
7.58
Enterprise Value/EBITDA
540.79
Financial Highlights
Profitability and Income Statement
Profit Margin
0.85%
Return on Assets (ttm)
-1.33%
Return on Equity (ttm)
1.03%
Revenue (ttm)
705.71M
Net Income Avi to Common (ttm)
6.01M
Diluted EPS (ttm)
0.21
Balance Sheet and Cash Flow
Total Cash (mrq)
439.66M
Total Debt/Equity (mrq)
3.84%
Levered Free Cash Flow (ttm)
-16.73M
Research Analysis: INSP
View MoreCompany Insights: INSP
INSP does not have Company Insights